- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations Investing
- Private Equity
- Real Estate
- Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Insurance Coverage and Recovery
- Intellectual Property, Patent, Trademark and Copyright Litigation
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- Careers
- News & Insights
- About
- Languages
Insight 3603 results
Client Alert
November 24, 2020
Are Pharma Speaker Programs Facing an Existential Crisis?
Client Alert
November 23, 2020
DIFC Courts Grant First Ever Anti-Suit Injunction
Client Alert
November 23, 2020
He Actually Did It: Trump Administration Implements Medicare Part B “Most Favored Nation” Drug Pricing Reform
Client Alert
November 23, 2020
Q3 2020: Latin American Enforcement Review
Newsletter
November 20, 2020
Compensation and Benefits Insights – November 2020
Article · Source: Food and Drug Law Institute
November 20, 2020
That Will Leave a Mark: FDA’s Shifting Approach to Regulating the Coronavirus Testing Market Creates Confusion, Opportunities, and Enforcement Risk
Client Alert
November 19, 2020
What Happened To My Interest Rate? Agencies Confirm SOFR Not Required
Client Alert
November 19, 2020
Heightened Focus on Foreign Influence in Academia
Article · Source: Thomson Reuters Practical Law Dispute Resolution Blog
November 19, 2020
Disclosure Pilot Scheme: Practical Guidance on the Duty of Cooperation
Article · Source: Islamic Finance News
November 18, 2020
Enforcement of Capital Commitment Structures in Saudi Arabia
Article · Source: For the Defense
November 17, 2020
An Evolving Landscape: The FDA's Regulation of Cannabis
Newsletter
November 16, 2020
Health Headlines – November 16, 2020